Amneal Pharmaceuticals, Inc.AMRXNASDAQ
LOADING
|||
| Metric | Dec 20 | Dec 21 | Dec 22 | Dec 23 | Dec 24 |
|---|---|---|---|---|---|
| Revenue | 1,993 | 2,094↑5.1% | 2,212↑5.7% | 2,394↑8.2% | 2,794↑16.7% |
| Gross Profit | 628 | 769↑22.4% | 791↑2.9% | 864↑9.1% | 1,020↑18.1% |
| Operating Income | 91 | 153↑67.5% | -95↓162.2% | 204↑315.3% | 249↑22.0% |
| Net Income | 91 | 11↓88.3% | -130↓1323.5% | -84↑35.4% | -117↓39.2% |
| EBITDA | 346 | 401↑16.1% | 440↑9.8% | 501↑13.8% | 440↓12.2% |
| EPS Diluted | 0.61 | 0.07↓88.5% | -0.86↓1328.6% | -0.48↑44.2% | -0.38↑20.8% |